IMCI Pharmaceuticals
Making Medical Cannabis: Safe, Reliable and Patient-focused
Startup Pre-Funding Health Tech & Life Sciences Est. 2018
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
3
1-10 employees
Confidence
98/100
News
4
articles
Patents
1
About
IMCI is a pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach. IMCI has developed a precise and effective dose together with an easy-to-use administration, suitable for any patient population at any time and place via its iCann medicinal cannabis platform.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Core Technology
BiologicalsHerbals
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B2CB2B
Tags
oncologydrug-developmentcannabispain-relieftreatmentspain-freetherapeuticsdrug-deliverydrug-discoverypharmaceuticalsbiopharmaceuticalmedical-cannabisbiotechnologycancerchronic-painpharma-companies
News (4)
Sep 15, 2024 · nocamels.com
growth-positive
No Smoking! Startup's To Safer Medical Cannabis
PartnersInvestment
Jun 2, 2023 · www.pharmatechoutlook.com
growth-positive
IMCI Pharmaceuticals: A Safer & Healthier Alternative to Consume Medicinal Cannabis-2023
CustomersPartnersExpand
Jul 10, 2022 · www.haaretz.com
growth-positive
The Next Generation of Cannabis Products Was Born in Israel
Expand
Mar 31, 2021 · www.startus-insights.com
growth-positive
Discover 5 Top HealthTechs working on Pain Management Solutions
CustomersInvestment
Details
Product Stage
R&D
Employees
1-10
Exact Count
6
District
Center District
Founded
2018
Locations
Gan Yavne, Israel
Riverside, New Bailey St, Salford M3 5FS, UK
Links
Website
LinkedIn
Admin
Last Update
Dec 22, 2024
Verified by
Yotam Maman
Claimed
Yes
Missing
funding rounds, markets
Team (3)
Alon Hershkovitz
Co-founder & CEO Israel
Founder
Avi Yakobovich
Co-founder & CEO South Africa
Founder
Gershon Ravid Rapaport
COO
Internal
Created by
Alon Hershkovitz (alonh2000@gmail.com)
Created
2020-10-18T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)